{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:17:55Z","timestamp":1791839875049,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jdcr.2023.09.024","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T04:15:05Z","timestamp":1696392905000},"page":"7-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab"],"prefix":"10.1016","volume":"42","author":[{"given":"Mysa","family":"Saad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetesh","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2023.09.024_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jdcr.2023.03.003","article-title":"Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab","volume":"35","author":"Zhao","year":"2023","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.jdcr.2023.09.024_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JRS-210048","article-title":"An old entity, a new trigger: post COVID-19 vaccine pityriasis rubra pilaris","volume":"32","author":"Sahni","year":"2021","journal-title":"Int J Risk Saf Med"},{"key":"10.1016\/j.jdcr.2023.09.024_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jdcr.2022.03.013","article-title":"Pityriasis rubra pilaris potentially triggered by messenger RNA\u20131273 COVID vaccine","volume":"23","author":"Ajebo","year":"2022","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.jdcr.2023.09.024_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamadermatol.2016.5384","article-title":"Interleukin 23-helper T cell 17 axis as a treatment target for pityriasis rubra pilaris","volume":"153","author":"Feldmeyer","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2023.09.024_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/ced.14970","article-title":"Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine","volume":"47","author":"Sechi","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"10.1016\/j.jdcr.2023.09.024_bib6","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1111\/jdv.18214","article-title":"Erythrodermic pityriasis rubra pilaris after SARS-CoV-2 vaccination with concomitant COVID-19 infection","volume":"36","author":"Gambichler","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jdcr.2023.09.024_bib7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00105-022-04972-z","article-title":"[Pityriasis rubra pilaris after COVID-19 vaccination: causal relationship or coincidence?]","volume":"73","author":"Bramhoff","year":"2022","journal-title":"Dermatologie (Heidelb)"},{"issue":"6","key":"10.1016\/j.jdcr.2023.09.024_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dth.15455","article-title":"Pityriasis rubra pilaris in association with inactivated SARS-CoV-2 vaccine (CoronaVac)","volume":"35","author":"Fern\u00e1ndez","year":"2022","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.jdcr.2023.09.024_bib9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamadermatol.2020.0932","article-title":"Evaluation of ixekizumab treatment for patients with pityriasis rubra pilaris: a single-arm trial","volume":"156","author":"Haynes","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2023.09.024_bib10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bjd.21708","article-title":"Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis","volume":"187","author":"Boudreaux","year":"2022","journal-title":"Br J Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623003673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623003673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:58Z","timestamp":1762475158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623003673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":10,"alternative-id":["S2352512623003673"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.09.024","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}